Azacitidine-eligibility in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: A registry-based study

Senthilkumar Durairaj, Norene Keenan, Ann Hyslop, Michael J. Groves, David T. Bowen, Sudhir Tauro

    Research output: Contribution to journalLetterpeer-review

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)280-282
    Number of pages3
    JournalBritish Journal of Haematology
    Issue number2
    Publication statusPublished - Apr 2013

    Cite this